CLINICAL_TRIALS
trial_result
· 2014-06-20
Clinical Trial Update: Comparison of Tiotropium in the HandiHaler Versus the Respimat in Chronic Obstructive Pulmonary Disease [Phase 3]
Summary
Phase 3 trial comparing tiotropium delivery by HandiHaler versus Respimat in chronic obstructive pulmonary disease; results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Boehringer Ingelheim | Conditions: Pulmonary Disease, Chronic Obstructive | Phase 3 | Status: COMPLETED | Results posted: 2014-06-20